|
Index of reports
> Cases resulting in other serious reactions (70)
> Cases with Breast Cancer Metastatic (13)
Below is the selection of adverse event reports related to Estrace (Estradiol Vaginal) that includes cases resulting in other serious reactions where reactions include breast cancer metastatic.
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Prempro
Estrace
Provera
Cycrin
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: hospitalization
Suspect drug(s):
Premarin
Dosage: unknown
Indication: Oestrogen Replacement Therapy
Start date: 1994-01-01
End date: 1996-01-01
Estrace
Provera
Dosage: unknown
Indication: Hormone Replacement Therapy
Start date: 1996-01-01
End date: 2002-01-01
Prempro
Dosage: unknown
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1996-01-01
End date: 2002-01-01
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: hospitalization
Suspect drug(s):
Prempro
Estradiol
Provera
Estrace
Premarin
Medroxyprogesterone Acetate
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a consumer/non-health professional from United States on 2007-10-29
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Prempro
Dosage: unknown
Indication: Hormone Replacement Therapy
Provera
Dosage: unknown
Indication: Hormone Replacement Therapy
Premphase 14 / 14
Dosage: unknown
Indication: Hormone Replacement Therapy
Estrace
Unspecified Estrogen Replacement Therapy
Dosage: unknown
Indication: Oestrogen Replacement Therapy
Cycrin
Dosage: unknown
Indication: Hormone Replacement Therapy
Medroxyprogesterone Acetate
Dosage: unknown
Indication: Hormone Replacement Therapy
Conjugated Estrogens
Premarin
Dosage: unknown
Indication: Oestrogen Replacement Therapy
Estratest
Dosage: unknown
Indication: Hormone Replacement Therapy
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a consumer/non-health professional from United States on 2007-10-12
Patient: female, weighing 65.8 kg (144.8 pounds)
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Premarin
Dosage: unknown
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1974-01-01
End date: 1980-08-01
Estrace
Dosage: unknown
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1980-01-01
End date: 2003-08-01
Provera
Dosage: unkonwn
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1974-01-01
End date: 2003-08-01
Adverse event in 66 year old female receiving Estrace (Estradiol Vaginal)
Reported by a consumer/non-health professional from United States on 2007-10-12
Patient: 66 year old female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Prempro
Indication: Menopausal Symptoms
Provera
Estrace
Medroxyprogesterone Acetate
Estropipate
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a lawyer from United States on 2007-10-08
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Prempro
Estrogens
Provera
Estrace
Estratest
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a consumer/non-health professional from United States on 2007-06-28
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Prempro
Indication: Hormone Replacement Therapy
Provera
Indication: Hormone Replacement Therapy
Estrace
Indication: Hormone Replacement Therapy
Premarin
Adverse event in 56 year old female receiving Estrace (Estradiol Vaginal)
Reported by a physician from United States on 2007-06-05
Patient: 56 year old female, weighing 63.5 kg (139.7 pounds)
Adverse reactions / side effects: Hysteroscopy, Liver Disorder, Fibrocystic Breast Disease, Uterine Leiomyoma, Liver Function Test Abnormal, Oedema Peripheral, Breast Microcalcification, Depression, Breast Hyperplasia, Pain in Extremity, Radiotherapy, Malignant Breast Lump Removal, Osteopenia, Hepatic Steatosis, Breast Cancer Metastatic, Uterine Dilation and Curettage, Menometrorrhagia
Suspect drug(s):
Estraderm
Dosage: 0.05mg
Indication: Hormone Replacement Therapy
Start date: 1990-12-01
End date: 1992-01-01
Premphase 14 / 14
Dosage: 0.625mg
Indication: Hormone Replacement Therapy
Start date: 1990-01-01
End date: 1999-10-01
Cycrin
Dosage: 10mg unk
Indication: Hormone Replacement Therapy
Start date: 1990-01-01
End date: 1992-01-01
Estratest
Indication: Hormone Replacement Therapy
Start date: 1990-01-01
End date: 2002-01-01
Premarin
Dosage: unk, unk
Indication: Hormone Replacement Therapy
Start date: 1993-07-01
End date: 1993-01-01
Provera
Dosage: unk, unk
Indication: Hormone Replacement Therapy
Start date: 1991-12-01
End date: 1996-01-01
Ogen
Indication: Hormone Replacement Therapy
Start date: 1999-01-01
End date: 2002-01-01
Estrace
Dosage: unk, unk
Indication: Hormone Replacement Therapy
Start date: 1993-01-01
End date: 1996-01-01
Prempro
Indication: Menopause
Start date: 2001-12-01
End date: 2002-01-01
Other drugs received by patient: Paxil; Xanax; Pamelor
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a consumer/non-health professional from United States on 2007-05-24
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Prempro
Premarin
Estrace
Femhrt
Provera
Medroxyprogesterone Acetate
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a consumer/non-health professional from United States on 2007-05-04
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Prempro
Dosage: unspecified
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1996-03-15
End date: 1999-10-28
Estrace
Dosage: unspecified
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1993-01-01
End date: 1996-03-15
Premarin
Indication: Oestrogen Replacement Therapy
Provera
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a consumer/non-health professional from United States on 2007-03-09
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: death
Suspect drug(s):
Premarin
Indication: Oestrogen Replacement Therapy
Estrace
Indication: Hormone Replacement Therapy
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a lawyer from United States on 2007-03-07
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic, Breast Cancer Female
Adverse event resulted in: death
Suspect drug(s):
Estradiol
Dosage: oral
Administration route: Oral
Start date: 1985-01-01
End date: 1999-01-01
Premarin
Dosage: oral
Administration route: Oral
Start date: 1985-01-01
End date: 1995-01-01
Estrace
Dosage: oral
Administration route: Oral
Start date: 1985-01-01
End date: 1999-01-01
|
